Table 2 Studies characteristics
Author, year | Study | Sites | No. | Type of surgery | Anesthesia | Intervention |
|---|---|---|---|---|---|---|
A. LUMPECTOMY/MASTECTOMY | ||||||
Campbell et al.,[10] 2014 | SB-RCT | New Zeland, 1 | 79 | Lumpectomy/Mastectomy ± ALND | ? | Local Infiltration |
Couceiro et al.,[11] 2014 | DB-RCT | Brazil, 1 | 44 | Mastectomy | GA | IV lidocaine |
Cros et al.,[12] 2018 | DB-RCT | France, 1 Canada, 1 | 127 | Lumpectomy/Mastectomy ± SLNB/ALND | GA | Pecs I |
Ferreira Laso et al.,[13] 2014 | DB-RCT | Spain, 1 | 73 | Mastectomy | GA | Infusion pump |
Gürkan et al.,[14] 2018 | SB-RCT | Turkey,? | 50 | Lumpectomy/Mastectomy ± SLNB/ALND | GA | ESP |
Ilfeld et al.,[15] 2014 | DB-RCT | US,? | 60 | Mastectomy ± ALND | Sedation | PVB |
Lanier et al .[16]2018 | DB-RCT | US,? | 45 | Mastectomy + reconstruction ± SLNB/ALND | ? | Intercostal + pectoral nerve blocks |
Mohamed et al.,[17] 2013 | DB-RCT | Egypt,? | 140 | Mastectomy ± ALND | GA | Local infiltration |
Neethu et al.,[18] 2018 | RCT | India, 1 | 60 | Mastectomy ± SLNB/ALND | GA | Pecs I - II |
Terkawi et al.,[19]2014 | DB-RCT | US,? | 71 | Mastectomy | GA | IV lidocaine |
Versyck et al.,[20] 2017 | DB-RCT | Belgium, 1 | 140 | Mastectomy/tumorectomy ±SLNB/ALND | GA | Pecs II |
Wang et al.,[21] 2018 | SB-RCT | China,? | 64 | Mastectomy + reconstruction ± ALND | GA | Pecs II |
Wang et al.,[22] 2019 | RCT | China,? | 61 | Mastectomy | GA | Pecs I + SPB |
Yao et al.,[23] 2019 | DB-RCT | China, 1 | 72 | Mastectomy ± ALND | GA | SPB |
B. BREAST AUGMENTATION | ||||||
Gardiner et al.,[24] 2012 | SB-RCT | Australia,? | 40 | BA | Sedation | PVB |
Picard et al.,[25] 2017 | SB-RCT | France,? | 72 | BA | ? | Local infiltration |
Schuitemaker et al.,[26] 2019 | DB-RCT | Spain,? | 30 | BA | GA | Pecs II + SPB |
C. BREAST REDUCTION | ||||||
Christie et al., [27] 2017 | DB-RCT | US, 1 | 40 | BR | GA | Tumescent Anaesthesia |
Valente et al.,[28] 2014 | DB-RCT | Brazil,? | 39 | BR | GA | Local infiltration |